Relation between ABO blood type antigen and antibody and acute vascular rejection in ABO incompatible kidney transplantation. 1998

A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
Department of Nephrology, Toho University, Tokyo, Japan.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
January 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
January 2022, Transplant international : official journal of the European Society for Organ Transplantation,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
August 2016, Clinical transplantation,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
March 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
December 2019, International journal of urology : official journal of the Japanese Urological Association,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
January 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
March 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
June 2014, Nephrology (Carlton, Vic.),
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
January 2019, Case reports in nephrology and dialysis,
A Aikawa, and T Hadano, and T Ohara, and A Hasegawa, and M Yamashita, and M Shindo, and T Mizuiri, and T Fushimi, and K Sakai, and N Hirayama, and K Arai, and E Tajima
January 2001, Transplantation proceedings,
Copied contents to your clipboard!